|POZEN Announces October 27 Webcast of Third Quarter Results|
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 13, 2005--POZEN Inc. (NASDAQ: POZN), announced today that it will release third quarter results on October 27, 2005, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m. Eastern Time of a discussion by POZEN management of the earnings and business results. The webcast can be accessed on POZEN's website at www.pozen.com and will be archived and available for replay. The third quarter earnings release can be accessed in the News section of POZEN's website.
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of migraine. POZEN is also exploring the development of product candidates in other pain-related therapeutic areas. POZEN has development and a commercialization alliance with GlaxoSmithKline. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.
SOURCE: POZEN Inc.